Skip to main content

Table 1 Inclusion and exclusion criteria for study participation in the NILS feasibility study

From: A lifestyle intervention among elderly men on active surveillance for non-aggressive prostate cancer: a randomised feasibility study with whole-grain rye and exercise

Inclusion criteria Exclusion criteria
Biopsy-proven prostate cancer within 2 years prior to enrolment Less than 10 years of life expectancy
PSA ≤ 10, Gleason score ≤ 6, clinical classification ≤ cT2a or PSA ≤ 10, Gleason score ≤ 7, clinical classification ≤ cT2a Prior history of cancer, except for non-melanoma skin cancer, unless considered cured without signs of treatment failure for at least 5 years
Maximum 1/5 tumour-positive biopsy rate Conditions or behaviours likely to affect the capability of participating fully in the intervention
On active surveillance (elected to forgo treatment) Moderate to severe co-morbidity (kidney, liver, heart, or respiratory problems)
Level of testosterone normal in sera Inflammatory bowel disease or physical handicaps
Above 55 and below 70 years of agea Gluten intolerance
  1. aWas adjusted to include the age span of 53–72 years